What are the plans of Redcliffe Labs to reach 500 million Indians and how are you going ahead on Network expansion? The company is planning to expand its operations in the country through a series of upcoming initiatives. Currently, Redcliffe Labs operates a nationwide network of
Federated Learning-based platform securely and rapidly enables access to anonymized and structured health data for research and collaboration. This will enable a collaborative engagement across healthcare ecosystem to create innovative AI solutions. Aster Innovation and Research Centre, the innovation hub of Aster DM Healthcare, has
The Hinduja supported MindMaze (“the Company”), a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced it has secured a $105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate the clinical development pipeline of its industry- defining
Takes charge to lead business innovation, strategy, Alliance & Partnerships Redcliffe Labs, also known as Redcliffe Life Diagnostics (https://redcliffelabs.com/), has recently appointed Abhay Singavi as Chief Business Officer (CBO). In his role, Abhay Singavi will be responsible to executing the company’s business strategy, driving the overall
Redcliffe Labs, also known as Redcliffe Life Diagnostics (https://redcliffelabs.com/), a unit of Redcliffe Lifetech in the U.S. and India, recently launched a large Regional Reference lab in Bangalore atREDCLIFFE LIFETECH PRIVATE LIMITED, Building No 168, 1st Floor, Sarathy, 9th Main, Sector 6, HSR Layout, Bangalore:
From the start of the pandemic, researchers, scientists, and antivirus specialists have worked around the clock to find a way to treat COVID-19. Codivir, an innovative new drug from Code Pharma, now appears to have the potential to revolutionize the fight against the virus. In
Even as we have possibly crossed the mayhem unleashed by the second wave of Covid-19 pandemic, the pertinent question lingering every Indian’s mind is whether or not our healthcare is equipped to handle any more unforeseen crisis of such magnitude. While we gradually return to
The chances of people developing mucormycosis (black fungus) post taking the vaccine are lower With herd immunity, the severity of 3rd wave will be less severe than 2nd wave Delta plus variant remains the cause of concern Antibodies produced by the vaccine protect against
Hanuman has a “No refusal policy”, a Bihar based Start-up offering digital aggregator of healthcare services since June 2020, was pioneered by four visionaries to challenge and streamline most devastating, neglected, high population in rural areas due to lack of awareness and unorganized healthcare sector
